Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Omeros Corp (NQ: OMER )

3.050 -0.160 (-4.98%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Omeros Corp

< Previous 1 2 3 4 5 6 7 8 9 Next >
OMER Stock Earnings: Omeros Misses EPS for Q4 2023
OMER stock results show that Omeros missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
From Omeros Corporation
Via Business Wire
Investor Sentiment Edges Lower, US Stocks Record Gains Last Quarter
The CNN Money Fear and Greed index showed a slight decline in overall market sentiment, but it remained in the "Greed" zone on Thursday. U.S. stocks closed mixed on Thursday, while the S&P 500 surged... 
Via Benzinga
Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024
From Omeros Corporation
Via Business Wire
Recap: Omeros Q3 Earnings
Via Benzinga
Earnings Preview: Omeros
Via Benzinga
Why Omeros Corporation (OMER) Shares Are Nosediving
Omeros Corp (NASDAQ: OMER) shares are trading lower by 47% to $1.20 during Monday's pre-market session. 
Via Benzinga
Earnings Scheduled For April 1, 2024
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Sleeping Giants: 3 Picks With Massive Upside by Mid-Decade
Discover three stocks with massive upside in oil and gas, data processing and outsourcing services, and pharmaceuticals sectors. 
Via InvestorPlace
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
From Omeros Corporation
Via Business Wire
3 Sleeper Stocks Under $15 Ready to Explode by 2029
Discover 3 under-$15 stocks primed for a 2029 explosion, from fintech disruptors to biotech pioneers tackling untreatable rare diseases. 
Via InvestorPlace
Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust
From Omeros Corporation
Via Business Wire
7 Short-Squeeze Stocks That Are Screaming for Speculation
If you like to march to your own beat even against high pressure, these short-squeeze stocks could be right for you. 
Via InvestorPlace
Top 5 Health Care Stocks That Are Ticking Portfolio Bombs
As of Dec. 5, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
Insiders Buying Taysha Gene Therapies And 3 Other Stocks Under $2
The Dow Jones closed higher by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
Omeros Corporation Reports Third Quarter 2023 Financial Results
From Omeros Corporation
Via Business Wire
Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2023
From Omeros Corporation
Via Business Wire
Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
From Omeros Corporation
Via Business Wire
Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting
From Omeros Corporation
Via Business Wire
Omeros Corporation Hires Andreas Grauer M.D. as Chief Medical Officer
From Omeros Corporation
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Crude Oil Moves Lower; Consolidated Communications Shares Jump
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining over 1% on Monday. The Dow traded up 0.93% to 33,983.22 while the NASDAQ rose 1.31% to 13,582.67. The S&P 500 also rose,... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday. 
Via Benzinga
Nasdaq Gains 1%; Charles Schwab Earnings Top Views
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday. The Dow traded up 1.02% to 34,012.79 while the NASDAQ rose 1% to 13,541.79. The S&P... 
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Surges Over 200 Points; Empire State Manufacturing Index Falls In October
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.72% to 33,913.22 while the NASDAQ rose 0.46% to 13,468.82. The S&P 500 also... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Omeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA Nephropathy
From Omeros Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.